Considerations for Using the HIRI-MSM Screening Tool to Identify MSM Who Would Benefit Most From PrEP

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):e58-e61. doi: 10.1097/QAI.0000000000001472.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / economics
  • Cost-Benefit Analysis
  • Decision Support Systems, Clinical* / economics
  • Decision Support Systems, Clinical* / statistics & numerical data
  • HIV Infections / prevention & control*
  • Homosexuality, Male*
  • Humans
  • Male
  • Mass Screening / methods*
  • Patient Selection
  • Practice Guidelines as Topic
  • Pre-Exposure Prophylaxis* / economics
  • Pre-Exposure Prophylaxis* / statistics & numerical data

Substances

  • Anti-HIV Agents